How has been the historical performance of Hind.Organ.Chem.?

Answer:The historical performance of Hind.Organ.Chem. shows significant fluctuations in key financial metrics over the years, with a notable recovery in the latest fiscal year.

Breakdown:
Hind.Organ.Chem. reported net sales of 535.87 Cr for the year ending March 2025, a decline from 703.89 Cr in March 2024 and 631.44 Cr in March 2023. The total operating income mirrored this trend, dropping to 535.87 Cr in March 2025 from 703.89 Cr in the previous year. The company's total expenditure, excluding depreciation, was 622.00 Cr in March 2025, down from 704.88 Cr in March 2024. This resulted in an operating profit (PBDIT) of -63.38 Cr for March 2025, a significant decrease from a profit of 15.70 Cr in March 2024. However, the profit before tax turned positive at 394.87 Cr in March 2025, compared to a loss of -55.32 Cr in March 2024, leading to a profit after tax of 391.54 Cr, a recovery from the previous year's loss of -55.32 Cr. The company's total assets were reported at 1,564.37 Cr in March 2025, slightly down from 1,572.34 Cr in March 2024, while total liabilities decreased to 1,564.37 Cr from 1,572.34 Cr. The cash flow from operating activities showed a positive trend with 631.00 Cr in March 2025, a recovery from -65.00 Cr in March 2024, indicating improved operational efficiency. Overall, while Hind.Organ.Chem. faced challenges in sales and operating profit, it demonstrated a strong recovery in profitability and cash flow in the latest fiscal year.